Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.02
-0.01 (-0.20%)
Jun 6, 2025, 4:08 PM HKT

HKG:9989 Statistics

Total Valuation

HKG:9989 has a market cap or net worth of HKD 17.62 billion. The enterprise value is 18.21 billion.

Market Cap 17.62B
Enterprise Value 18.21B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date Aug 29, 2025
Ex-Dividend Date May 26, 2025

Share Statistics

Current Share Class 220.09M
Shares Outstanding n/a
Shares Change (YoY) +0.05%
Shares Change (QoQ) -0.70%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 422.05M

Valuation Ratios

The trailing PE ratio is 25.35.

PE Ratio 25.35
Forward PE n/a
PS Ratio 3.11
PB Ratio 1.33
P/TBV Ratio 1.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 26.20
EV / Sales 3.16
EV / EBITDA n/a
EV / EBIT 36.18
EV / FCF n/a

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.29.

Current Ratio 2.55
Quick Ratio 1.18
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 5.09

Financial Efficiency

Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 2.28%.

Return on Equity (ROE) 5.12%
Return on Assets (ROA) 2.07%
Return on Invested Capital (ROIC) 2.28%
Return on Capital Employed (ROCE) 4.41%
Revenue Per Employee 2.94M
Profits Per Employee 360,892
Employee Count 1,926
Asset Turnover 0.29
Inventory Turnover 0.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +43.43% in the last 52 weeks. The beta is 0.37, so HKG:9989's price volatility has been lower than the market average.

Beta (5Y) 0.37
52-Week Price Change +43.43%
50-Day Moving Average 4.57
200-Day Moving Average 4.15
Relative Strength Index (RSI) 60.18
Average Volume (20 Days) 2,225,900

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:9989 had revenue of HKD 5.66 billion and earned 695.08 million in profits. Earnings per share was 0.47.

Revenue 5.66B
Gross Profit 1.77B
Operating Income 646.57M
Pretax Income 775.46M
Net Income 695.08M
EBITDA n/a
EBIT 646.57M
Earnings Per Share (EPS) 0.47
Full Income Statement

Balance Sheet

The company has 3.33 billion in cash and 3.85 billion in debt, giving a net cash position of -526.77 million.

Cash & Cash Equivalents 3.33B
Total Debt 3.85B
Net Cash -526.77M
Net Cash Per Share n/a
Equity (Book Value) 13.23B
Book Value Per Share 8.98
Working Capital 6.43B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 31.19%, with operating and profit margins of 11.42% and 12.28%.

Gross Margin 31.19%
Operating Margin 11.42%
Pretax Margin 13.70%
Profit Margin 12.28%
EBITDA Margin n/a
EBIT Margin 11.42%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 5.41%.

Dividend Per Share 0.27
Dividend Yield 5.41%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.05%
Shareholder Yield 5.36%
Earnings Yield 3.95%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:9989 has an Altman Z-Score of 2.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.77
Piotroski F-Score n/a